CERULEAN PHARMA

Cerulean Pharma Inc. is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases. The Company has assembled a world-class management team, board of directors and scientific advisory board that collectively have a significant track record of business building, product development and scientific breakthroughs from companies and institutions such as Cubist, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Inc., Pfizer, Wyeth, the Massachusetts Institute of Technology, Harvard Medical School, MD Anderson, Fox Chase Cancer Center and the Arizona Health Center.
CERULEAN PHARMA
Industry:
Biotechnology Health Care Nanotechnology Therapeutics
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.darebioscience.com
Total Employee:
11+
Status:
Active
Contact:
(617)494-1544
Total Funding:
152.7 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Facebook Sharer AWS Global Accelerator Akamai Hosted
Current Advisors List
Board_member
Board_member
2006-01-01
Board_member
Board_member
Board_member
Current Employees Featured
Jean Silveri Senior Vice President, General Counsel @ Cerulean Pharma
Senior Vice President, General Counsel
Oliver Fetzer President and Chief Executive Officer @ Cerulean Pharma
President and Chief Executive Officer
Rob Paull Director @ Cerulean Pharma
Director
Chris Guiffre Senior Vice President and Chief Business Officer @ Cerulean Pharma
Senior Vice President and Chief Business Officer
Scott Eliasof Vice President, Research @ Cerulean Pharma
Vice President, Research
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Cerulean Pharma
Lux Capital
Lux Capital investment in Private Equity Round - Cerulean Pharma
Bessemer Venture Partners
Bessemer Venture Partners investment in Private Equity Round - Cerulean Pharma
Venrock
Venrock investment in Private Equity Round - Cerulean Pharma
Polaris Partners
Polaris Partners investment in Private Equity Round - Cerulean Pharma
CVF
CVF investment in Private Equity Round - Cerulean Pharma
Lilly Ventures
Lilly Ventures investment in Private Equity Round - Cerulean Pharma
Lux Capital
Lux Capital investment in Series D - Cerulean Pharma
Lilly Ventures
Lilly Ventures investment in Series D - Cerulean Pharma
Venrock
Venrock investment in Series D - Cerulean Pharma
Official Site Inspections
http://www.darebioscience.com
- Host name: 162-144-1-80.unifiedlayer.com
- IP address: 162.144.1.80
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606

More informations about "Cerulean Pharma"
About - Daré Bioscience
May 25, 2024 We are genuine, respectful, authentic and have high ethical standards: We value each other and always work in the best interest of Daré; We succeed by doing the right thingsSee details»
Home | Daré Bioscience
We DARE to address decades of unmet needs in women’s health by bringing to market innovative evidence-based treatment solutions primarily in the areas of contraception, sexual health, …See details»
Dare Bioscience, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Dare Bioscience, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Sabrina Martucci Johnson - Daré Bioscience
Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, …See details»
Dare Bioscience - Crunchbase Company Profile & Funding
Organization. Dare Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Daré Bioscience is a healthcare …See details»
Daré Bioscience (DARE) Company Profile & Description - Stock …
Apr 17, 2025 Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women’s health in the United States. It develops therapies in the areas of …See details»
Daré Bioscience, Inc. Overview | SignalHire Company Profile
Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class …See details»
Daré Bioscience, Inc. Information - RocketReach
Darebioscience.com; 2 858658XXXX; 619370XXXX; View Similar People. Related Companies ViaCyte. 31 $10.3b Evofem Biosciences. 60 $17.7m Mirati Therapeutics. 249 $46.5b Evoke …See details»
Dare Bioscience Company Profile - Office Locations, Competitors …
Oct 29, 2024 Dare Bioscience has 4 employees at their 1 location and $2.81 m in annual revenue in FY 2023. See insights on Dare Bioscience including office locations, competitors, …See details»
Dare Bioscience Inc Company Profile | La Jolla, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Dare Bioscience Inc of La Jolla, CA. Get the latest business insights from Dun & Bradstreet.See details»
Daré Bioscience - Devex
Learn more about Daré Bioscience's jobs, projects, latest news, contact information and geographical presence. At Daré, they believe women’s health is an important therapeutic area …See details»
Daré Bioscience - Overview, News & Similar companies - ZoomInfo
May 7, 2024 Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024 SAN DIEGO, May 07, 2024 (GLOBE …See details»
Investors | Daré Bioscience
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and …See details»
Daré Bioscience, Inc.
Mar 6, 2025 Contacts: Daré Bioscience Investor Relations innovations@darebioscience.com Source: Daré Bioscience, Inc. Source: Daré Bioscience, Inc. License out/in Drug Approval …See details»
Dare Bioscience Company Profile -Sales, Contacts, Competitors – …
Dare Bioscience, Inc. (trade name Darebio) is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Daré Bioscience - CEO and Investor Conference 2025
Feb 10, 2025 Daré Bioscience is a biopharmaceutical company committed to advancing innovative products for women’s health. The company’s mission is to identify, develop and …See details»
Daré Bioscience to Present at 2021 BIO Digital
SAN DIEGO, June 04, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it has been selected to deliver a …See details»
Daré Bioscience Secures $12 million in Royalty-backed Investment ...
Dec 26, 2023 $5 million at closing and up to $7 million of additional committed funding. SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a …See details»
Daré Bioscience Reports Full Year 2024 Financial Results and …
Mar 31, 2025 The ongoing Phase 1 study is being conducted by FHI 360, a nonprofit organization, with support from a foundation grant. There are no development costs to Daré at …See details»
Dare Bioscience, Inc. - Cruelty Free Investing
Company Website: https://www.darebioscience.com Contact: innovations@darebioscience.com ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit …See details»